Document:

Exhibit 10.1

                          CONSULTING SERVICE AGREEMENT

  THIS CONSULTING SERVICE AGREEMENT is made effective this 1st day of September,
                                  2002 by and;

BETWEEN:

     GUARDIAN  BIOTECHNOLOGIES INC. OF IPW, 110 GYMNASIUM PLACE, SASKATOON, SK.,
     CANADA  S7N  0W9
     (HEREINAFTER  REFERRED  TO  AS  "GUARDIAN")

AND:

     CONSULTANT,  DR.  SUN  LEE,  OF 65-1, WONCHON-DONG, YUSUNG-GU, DAEJON CITY,
     REPUBLIC  OF  KOREA

WHEREAS:

A.   Dr.  Sun  Lee  is  the  president  of NEXGEN TECHNOLOGIES INC. (hereinafter
     referred  to  as  "NEXGEN"),  which  is  engaged in conducting research and
     development  of  molecular  farming  and  providing  screening services for
     genetically  engineered  organism  ("GMO")  in  Korea;

B.   GUARDIAN  is  a  newly incorporated firm which targets molecular farming in
     Canada  for  the  long-term  and  GMO  services  and  sales  of  scientific
     instruments  in  North  America  for  short-term;  and

C.   GUARDIAN considers it to be in its best interest to engage Dr. Sun Lee as a
     consultant to receive consulting services with regard to molecular farming,
     GMO  services  and  the  sales  of  scientific instruments on the terms and
     subject  to  the  conditions  hereinafter  set  forth.

NOW THEREFORE THIS AGREEMENT WITNESS THAT THE PARTIES MUTUALLY AGREE AS FOLLOWS:

1.   ENGAGEMENT
     ----------

1.1  Subject to the terms and conditions hereof, GUARDIAN hereby engages Dr. Sun
     Lee  to  receive  the  marketing consulting services set out in Section 2.1
     hereof  (the  "Services").

1.2  Dr.  Sun  Lee's obligation to perform the Services shall commence following
     the  completion  of  the  list  of the Services, and will continue from the
     Effective  Date  until  terminated in accordance with Article 4 hereof (the
     "Term").

2.   SERVICES
     --------

2.1  Provide and/or help GUARDIAN to develop gene designs, which will be used in
     establishing  molecular  farming  in  Canadian  Market.

2.2  Assist  GUARDIAN  in  establishing  its  business  in Canada with regard to
     staffing,  administration,  preparation of corporate records, and set-up of
     place  of  its  business  and  equipment  for  research  and  development.

<PAGE>

2.3  Assist  in  transferring  NEXGEN's  proprietary  technologies necessary for
     GUARDIAN  to  provide  GMO  services  in  Canada.

2.4  Assist  GUARDIAN in negotiating with ToyLab, which is a Korean manufacturer
     of  scientific instruments that will be imported to Canada for distribution
     by  GUARDIAN.

3.   CONSIDERATION
     -------------

3.1  In  consideration  for the Services, GUARDIAN shall pay Dr. Sun Lee $80,000
     CAD  annually.

4.   TERMINATION  AND  RENEWAL
     -------------------------

4.1  This  agreement  may  be  terminated by GUARDIAN upon the occurrence of any
     default  by  Dr. Sun Lee by giving written notice to Dr. Sun Lee specifying
     the  nature  of the default. A default will be defined as the occurrence of
     any  one  ore  more  of  the  following:

     a.   Dr.  Sun  Lee  fails  to  perform any of the Services in the manner or
          within  the  time required herein or commits or permits a breach of or
          default  in  any  of  Dr.  Sun  Lee's covenants, duties or obligations
          hereunder;  or
     b.   GUARDIAN  acting  reasonably determines that Dr. Sun Lee or any of his
          agents  or  employees  has  acted,  is acting or is likely to act in a
          manner  detrimental to GUARDIAN or has violated the confidentiality of
          any  information  as  provided  for  in  this  agreement.

4.2  This  agreement may be renewed for consecutive one year terms, on an annual
     basis,  as  agreed  to  by  both  parties  at  the  end  of  the  Term.

5.   LAW
     ---

5.1  This  agreement  shall  be governed by and construed in accordance with the
     laws of the Province of British Columbia and the parties hereby irrevocably
     attorn  to  the  courts  of  such  Province.

IN  WITNESS  THEREOF,  the  parties  above have caused this Agreement to be duly
executed,  as  of  the  day  and  year  set  out  below.

GUARDIAN  BIOTECHNOLOGIES  INC.

By:      /s/ SCOTT LEE                                       September  1,  2002
     -------------------------------------                   -------------------
        Scott  Lee,  Director                                   Date

CONSULTANT

By:       /s/ SUN LEE                                        September  1,  2002
      -------------------------------------                  -------------------
        Dr.  Sun  Lee                                        DateExhibit 10.2

                              EMPLOYMENT AGREEMENT
                              --------------------

Employment  Agreement, between Guardian Biotechnologies Inc. (the "Company") and
James  Macpherson  (the  "Employee").

1.   For good consideration, the Company employees the Employee on the following
     terms  and  conditions.

2.   Term  of  Employment.  This  agreement will begin on October 1st, 2002, and
     continue  to  remain  effective  until September 30th , 2003, unless sooner
     terminated.
     The  Term  of  Employment shall be automatically extended for an additional
     one-year  period  unless the Employee or Company provide(s) the other party
     one month prior written notice before the next Extension Date that the Term
     of  Employment  shall  not  be  so  extended.

3.   Salary.  The  Company  shall pay Employee a salary of $66,000 per year, for
     the  services  of  the  Employee,  payable  at  regular  payroll  periods.

4.   Stock  Options  may  be given to the Employee as a bonus at its discretion.

5.   Duties  and  Position.  The  Company  hires the Employee in the capacity of
     General  Manager.  The  Employee's duties may be reasonably modified at the
     Company's  discretion  from  time  to  time.

6.   Confidentiality  or  Proprietary  Information.  Employee  agrees, during or
     after  the term of this employment, not to reveal confidential information,
     or  trade  secrets  to  any  person,  firm,  corporation, or entity. Should
     Employee  reveal  or threaten to reveal this information, the Company shall
     be entitled to an injunction restraining the Employee from disclosing same,
     or  from  rendering any services to any entity to whom said information has
     been or is threatened to be disclosed. The right to secure an injunction is
     not exclusive, and the Company may pursue any other remedies it has against
     the Employee for a breach or threatened breach of this condition, including
     the  recovery  of  damages  from  the  Employee.

7.   Reimbursement  of  Expenses. The Employee may incur reasonable expenses for
     furthering  the  Company's  business, including expenses for entertainment,
     travel,  and  similar  items.  The Company shall reimburse Employee for all
     business  expenses  after  the  Employee  presents  an  itemized account of
     expenditures,  pursuant  to  Company  policy.

8.   Vacation. The Employee shall be entitled to a yearly vacation of 3 weeks at
     full  pay.

9.   Termination  of  Agreement.  Without  cause, the Company may terminate this
     agreement  at  any time upon 14 days written notice to the Employee. If the
     Company  requests, the Employee will continue to perform his/her duties and
     may  be  paid his/her regular salary up to the date of termination. Without
     cause,  the  Employee may terminate employment upon 14 days' written notice
     to  the  Company. Employee may be required to perform his or her duties and
     will  be  paid  the  regular  salary  to  date  of  termination.

10.  Governing  Law.  This  agreement  shall  be  governed  by  and construed in
     accordance  with the laws of the Province of Saskatchewan without regard to
     principles  of  conflict  of  laws.

<PAGE>

11.  Assumption  of  Agreement  by  Company's  Successors  and  Assignees.  The
     Company's  rights  and  obligations  under this agreement will inure to the
     benefit  and  be  binding  upon  the  Company's  successors  and assignees.

12.  Oral  Modifications Not Binding. This instrument is the entire agreement of
     the  Company  and  the  Employee.  Oral  changes  have no effect. It may be
     altered  only  by  a  written  agreement  signed  by the party against whom
     enforcement of any waiver, change, modification, extension, or discharge is
     sought.

     Signed  this  1st  day  of  October  2002.

           /s/                           /s/ JAMES MACPHERSON
-------------------------------          --------------------
Guardian  Biotechnologies  Inc.          James  MacphersonExhibit 10.1

EXHIBIT 10.1

                              YEAR 2003 STOCK GRANT

1. Purpose. This Year 2003 Stock Grant (the 'Grant') of Yi Wan Group, Inc.
(the 'Company') for selected employees, officers, directors and key consultants
and advisors to the Company is intended to advance the best interests of the
Company by providing personnel who have substantial responsibility for the
management and growth of the Company and its subsidiaries with additional
incentive by increasing their proprietary interest in the success of the
Company, thereby encouraging them to remain in the employ of the Company or any
of its subsidiaries.

2. Administration. The Grant shall be administered by the Board of Directors of
the Company (the 'Board') which shall keep the minutes of its proceedings with
regard to the Grant and all records, documents, and data pertaining to its
administration of the Grant. A majority of the members of the Board shall
constitute a quorum for the transaction of business, and the vote of a majority
of those members present at any meeting shall decide any question brought before
that meeting. In addition, the Board may take any action otherwise proper under
the Grant by the affirmative vote, taken without a meeting, of a majority of its
members. Any decision or determination reduced to writing and signed by a
majority of the members shall be as effective as if it had been made by a
majority vote at a meeting properly called and held. All questions of
interpretation and application of the Grant shall be subject to the
determination of the Board. The actions of the Board in exercising all of the
rights, powers and authorities set out in this Grant, when performed in good
faith and in its sole judgment, shall be final, conclusive, and binding on the
parties.

3. Shares Available Under the Grant. The stock subject to the Stock Grants shall
be shares of the Company's Common Stock, no par value, (the 'Common Stock'). The
total number of shares of Common Stock available under the Grant shall be
250,000 shares of Common Stock. The number of shares offered under this Grant
may be increased by a majority vote of the Board of Directors. Such shares may
be treasury shares or authorized but unissued shares.

4. Eligibility. The individuals who shall be eligible to participate shall be
any officer, director, employee, consultant, advisor or other person providing
key services to the Company who are not engaged in any prohibited
activity (hereinafter such persons may sometimes be referred to as the 'Eligible
Individuals.') Prohibited Activity shall include the following:
i. services rendered to the Company not in connection with a capital raising
or market making transaction;
ii. services in connection with the offer or sale of securities in a
capital-raising transaction that directly or indirectly promotes or maintains a
market for the Company's securities;
iii. services by current or future auditors of the Company;
iv. services performed by compensate promoters of the Company;
v. services involving any promotion or marketing of the Company or shareholder
or investor relations services; and
vi. services in connection with a shell merger.

5. Authority to Grant Stock Grants. The Board in its discretion and subject to
the provisions of the Grant, may grant the following from time to time to
eligible individuals of the Company:
Stock Grants. The Board may Grant and issue shares of Common Stock under the
Grant to an eligible individual ('Stock Grant'). Stock Grants may be made in
lieu of cash compensation or as additional compensation. Stock Grants may also
be made pursuant to performance based goals established by the Board.

Subject only to any applicable limitations set forth in the Grant, the number of
shares of Common Stock covered by any Stock Grant, shall be determined by the
Board.

6. Stock Grants.
(a) Grants in Lieu of Compensation. The Board may grant Common Stock to an
Eligible Individual under the Grant, without any payment by the individual, in
lieu of certain cash compensation or as additional compensation. The Stock Grant
is subject to appropriate tax withholding. After compliance with the tax
withholding requirements, a stock certificate shall be issued to the individual
recipient of the Stock Grant. The certificate shall bear such legend, if any, as
the Board determines is reasonably required by applicable law. Prior to receipt
of a Stock Grant, the individual must comply with appropriate requests of the
Board to assure compliance with all relevant laws.
(b) Performance Based Grants. The Board may Grant shares of Common Stock,
without any payment for such shares, to designated individuals if specified
performance goals established by the Board are satisfied. The designation of an
employee eligible for a specific performance based Stock Grant shall be made by
the Board in writing prior to the beginning of the 12-month period for which the
performance is measured. The Board shall establish the number of shares to be
issued to a designated employee if the performance goal is met. The Board must
certify in writing that a performance goal has been met prior to issuance of any
certificate for a performance based Stock Grant to any employee. If the Board
certifies the entitlement of an employee to the performance based Stock Grant,
the certificate shall be issued to the employee as soon as administratively
practicable, and subject to other applicable provisions of the Grant, including
but not limited to, all legal requirements and tax withholding. Performance
goals determined by the Board may be based on specified increases in net
profits, stock price, Company or segment sales, market share, earnings per
share, and/or return on equity.

7. The Company may, but shall not be obligated to, register any securities
covered by a Stock Grant pursuant to the 1933 Act (as now in effect or as
hereafter amended) and, in the event any shares are registered, the Company may
remove any legend on certificates representing these shares. The Company shall
not be obligated to take any other affirmative action in order to cause the
Stock Grant to comply with any law or regulation of any governmental authority.

8. Employment Obligation. The granting of any Stock Grant shall not impose upon
the Company any obligation to employ or continue to employ any grantee; and the
right of the Company to terminate the employment of any officer or other
employee shall not be diminished or affected by reason of the fact that a Stock
Grant has been granted to him.

9. Changes in the Company's Capital Structure. The existence of outstanding
Stock Grants shall not affect in any way the right or power of the Company or
its shareholders to make or authorize any or all adjustments, recapitalizations,
reorganizations or other changes in the Company's capital structure or its
business, or any merger or consolidation of the Company, or any issue of bonds,
debentures, preferred or prior preference stock ahead of or affecting the Common
Stock or the rights thereof, or the dissolution or liquidation of the Company,
or any sale or transfer of all or any part of its assets or business, or any
other corporate act or proceeding, whether of a similar character or otherwise.
If the Company effects a subdivision or consolidation of shares or other capital
readjustment, the payment of a dividend in capital stock or other equity
securities of the Company on, its Common Stock, or other increase or reduction
of the number of shares of the Common Stock outstanding, without receiving
consideration therefor in money, services, or property, or the reclassification
of its Common Stock, in whole or in part, into other equity securities of the
Company, then (a) the number, class and per share price of shares of Common
Stock subject to Stock Grants hereunder shall be appropriately adjusted (or in
the case of the issuance of other equity securities as a dividend on, or in a
reclassification of, the Common Stock, the Stock Grants shall extend to such
other securities) in a manner so as to entitle a grantee to receive, for the
same aggregate cash consideration, and for a Grant of pending performance based
Stock Grants, the same total number and class or classes of shares or in the
case of a dividend of, or reclassification into, other equity securities, those
other securities) he would have held after adjustment if the Stock Grant was
earned, immediately prior to the event requiring the adjustment, or, if
applicable, the record date for determining shareholders to be affected by the
adjustment; and (b) the number and class of shares then reserved for issuance
under the Grant(or in the case of a dividend of, or reclassification into, other
equity securities, those other securities) shall be adjusted by substituting for
the total number and class of shares of stock then reserved, the number and
class or classes of shares of stock (or in the case of a dividend of, or
reclassification into, other equity securities, those other securities) that
would have been received by the owner of an equal number of outstanding shares
of Common Stock as a result of the event requiring the adjustment. Comparable
rights shall accrue to each employee in the event of successive subdivisions,
consolidations, capital adjustments, dividends or reclassifications of the
character described above. Appropriate adjustments shall also be made to pending
Stock Grants. Except as hereinbefore expressly provided, the issue by the
Company of shares of stock of any class, or securities convertible into shares
of stock of any class, for cash or property, or for labor or services either
upon direct sale or upon the exercise of rights or warrants to subscribe
therefor, or upon conversion of shares or obligations of the Company convertible
into such shares or other securities, shall not affect, and no adjustment by
reason thereof shall be made with respect to, the number or price of shares of
Common Stock then subject to outstanding Stock Grants.

10. Amendment or Termination of Grant. The Board may at any time alter, suspend,
amend, or terminate the Grant.

11. Forfeitures. Notwithstanding any other provisions of this Grant, if the
Board finds by a majority vote after full consideration of the facts that the
employee, before or after termination of his employment with the Company or its
subsidiaries for any reason (a) committed or engaged in fraud, embezzlement,
theft, commission of a felony, or proven dishonesty in the course of his
employment by the Company or its subsidiaries, which conduct damaged the Company
or its subsidiaries, or disclosed trade secrets of the Company or its
subsidiaries, or (b) participated, engaged in or had a financial or other
interest, whether as an employee, officer, director, consultant, contractor,
shareholder, owner, or otherwise, in any commercial endeavor in the United
States which is competitive with the business of the Company or its subsidiaries
without the written consent of the Company or its subsidiaries, the employee
shall forfeit all outstanding Stock Grants which are not fully vested, including
all rights related to such matters, and including any performance based Stock
Grants to which he may be entitled, and other elections pursuant to which the
Company has not yet delivered a stock certificate. Clause (b) shall not be
deemed to have been violated solely by reason of the employee's ownership of
stock or securities of any publicly owned corporation, if that ownership does
not result in effective control of the corporation. The decision of the Board as
to the cause of the employee's discharge, the damage done to the Company or its
subsidiaries, and the extent of the employee's competitive activity shall be
final. No decision of the Board, however, shall affect the finality of the
discharge of the employee by the Company or its subsidiaries in any manner. To
provide the Company with an opportunity to enforce this Section, no certificate
for Stock may be issued under this Grant without the certification by the Board
that no action forbidden by this provision has been raised for their
determination.

12. Tax Withholding. The Company shall be entitled to deduct from other
compensation payable to each employee any sums required by federal, state, or
local tax law to be withheld with respect to the grant, vesting, as appropriate,
of an Stock Grant. In the alternative, the Company may require the employee (or
other person receiving the Stock Grant) to pay the sum directly to the employer
corporation.

13. Written Agreement. Each Stock Grant granted hereunder shall be embodied in a
written agreement, which shall be subject to the terms and conditions prescribed
herein, and shall be signed by the grantee and by an appropriate officer of the
Company on behalf of the Company. Each agreement shall contain other provisions
which the Board in its discretion shall deem advisable.

14. Governing Law and Interpretation. This Grant shall be governed by the laws
of the state of Florida. Headings contained in this are for convenience only and
shall in no manner be construed as part of this Grant.

15. Effective Date. This Grant shall become effective as of December 1, 2002
(the 'Effective Date') and shall terminate on the 1st anniversary of the
Effective Date.

Accepted by the Board of Directors

   /s/ Cheng Wan Ming
Cheng Wan Ming, President and Chairman of the Board

   /s/ Wu Zeming
Wu Zeming, Chief Financial Officer and Director

   /s/ You Yingliu
You Yingliu, Director

   /s/ Zhang Haoyu
Zhang Haoyu, Director

   /s/ Yang Huijuan
Yang Huijuan, Director

   /s/ Luo Guanying
Luo Guanying, Director

   /s/ Liang Xiaogen
Liang Xiaogen, Director

   /s/ Cheng Manli
Cheng Manli, Director

   /s/ Cen Minhong
Cen Minhong, Director

   /s/ Cheng Wanqing
Cheng Wanqing, Director

   /s/ Cheng Deqiang
Cheng Deqiang, Director

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00045-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00045-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00045-of-00352.parquet"}]]